Medication Guide App

BNVA 150 (Boniva 150 mg)

Generic Name: ibandronate

Pill imprint BNVA 150 has been identified as Boniva 150 mg.

Boniva is used in the treatment of prevention of osteoporosis; osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for BNVA 150

Boniva 150 mg BNVA 150 Front
Boniva 150 mg BNVA 150 Back
Boniva 150 mg BNVA 150
Boniva
Generic Name:
ibandronate
Imprint:
BNVA
150
Strength:
150 mg
Color:
White
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Bisphosphonates
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-0186
Inactive Ingredients:
lactose monohydrate
povidone k25
microcrystalline cellulose
crospovidone
stearic acid
silicon dioxide
water
hypromelloses
titanium dioxide
magnesium silicate
polyethylene glycol 6000
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0400 Stat RX USA LLC (repackager)
54868-5322 Physicians Total Care Inc (repackager)
35356-0423 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)